Palisade Bio (PALI) Other Operating Expenses (2021 - 2025)
Historic Other Operating Expenses for Palisade Bio (PALI) over the last 9 years, with Q3 2025 value amounting to -$1.5 million.
- Palisade Bio's Other Operating Expenses rose 8994.31% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 12045.9%. This contributed to the annual value of -$5.5 million for FY2024, which is 626.28% up from last year.
- Palisade Bio's Other Operating Expenses amounted to -$1.5 million in Q3 2025, which was up 8994.31% from -$1.1 million recorded in Q2 2025.
- In the past 5 years, Palisade Bio's Other Operating Expenses ranged from a high of $30.1 million in Q2 2021 and a low of -$15.1 million during Q3 2024
- In the last 5 years, Palisade Bio's Other Operating Expenses had a median value of -$1.2 million in 2025 and averaged $1.6 million.
- In the last 5 years, Palisade Bio's Other Operating Expenses soared by 329466.67% in 2024 and then soared by 210.76% in 2025.
- Over the past 5 years, Palisade Bio's Other Operating Expenses (Quarter) stood at $30.1 million in 2021, then plummeted by 98.64% to $410000.0 in 2022, then tumbled by 45.12% to $225000.0 in 2023, then soared by 3294.67% to $7.6 million in 2024, then plummeted by 119.89% to -$1.5 million in 2025.
- Its last three reported values are -$1.5 million in Q3 2025, -$1.1 million for Q2 2025, and -$1.3 million during Q1 2025.